MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
472
Beneficiaries
—
Total drug cost
$3.2M
Distinct drugs
13
Brand share
87.5%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala104 claims
Abacavir/Dolutegravir/Lamivudi84 claims
Dolutegravir/Rilpivirine63 claims
Dolutegravir Sodium37 claims
Darunavir/Cobicistat34 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE